Print

RV 305(A)

Randomized, Double Blind Evaluation of Late Boost Strategies for HIV-uninfected Participants in the HIV Vaccine Efficacy Trial RV 144: "Aventis Pasteur Live Recombinant ALVAC-HIV (vCP1521) Priming With VaxGen gp120 B/E (AIDSVAX B/E) Boosting in HIV-uninfected Thai Adults

Trial Details:

II Ongoing
U.S. Military HIV Research Program (MHRP) April 01, 2012
ALVAC-HIV vCP1521,AIDSVAX B/E
ALVAC-HIV vCP1521 Viral Vector - Pox
AIDSVAX B/E Protein
Thailand 162
NCT01435135
http://clinicaltrials.gov/ct2/show/NCT01435135?term=rv+305&rank=1